The study provides evidence for a second pathway of activation of the nicotinic acetylcholine receptor channel by (-)physostigmine, distinct from the primary acetylcholine binding site.
No takes yet. Share an insight, caveat, or question.
Suggests an allosteric nAChR activation site in animals; leaves open relevance to human cardiovascular therapies.
Okonjo et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: